Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. - sprookjes - yvandenbroek - TriplyDB

Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.

Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.

http://www.wikidata.org/entity/Q46664735

about

Brain tumors Application of Different Imaging Methods in the Early Diagnosis of Primary Hepatic Carcinoma Utility of diffusion tensor imaging in evaluation of the peritumoral region in patients with primary and metastatic brain tumors Is there a role for PET-CT and SPECT-CT in pediatric oncology?Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.Progress on the diagnosis and evaluation of brain tumors.Molecular imaging of brain tumors with radiolabeled choline PET.Switching on the lights for real-time multimodality tumor neuroimaging: The integrated positron-emission tomography/MR imaging system.Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.Molecular imaging of gliomas with PET: opportunities and limitations.Differential kinetics of α-[¹¹C]methyl-L-tryptophan on PET in low-grade brain tumors.Increased L-[1-11 C] leucine uptake in the leptomeningeal angioma of sturge-weber syndrome: a PET study Correlation between the Uptake of 18F-Fluorodeoxyglucose (18F-FDG) and the Expression of Proliferation-Associated Antigen Ki-67 in Cancer Patients: A Meta-Analysis Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using 11C-Choline and 18F-FDG PET/CT.Use of Labelled tLyP-1 as a Novel Ligand Targeting the NRP Receptor to Image Glioma Prognostic Value of Metabolic Tumor Volume on (11)C-Methionine PET in Predicting Progression-Free Survival in High-Grade Glioma.Potential role for magnetoencephalography in distinguishing low- and high-grade gliomas: a preliminary study with histopathological confirmation.Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1-(13)C]pyruvate.Simultaneous 11C-Methionine Positron Emission Tomography/Magnetic Resonance Imaging of Suspected Primary Brain Tumors.18F-fluorothymidine PET imaging in gliomas: an update.Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging.Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography Achievement of three year remission in a case of aggressive glioblastoma using a multidisciplinary treatment strategy: A case report.The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review.Novel positron emission tomography radiotracers in brain tumor imaging.Amino acid PET and MR perfusion imaging in brain tumours.The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging.Optimization of scan initiation timing after 11C-methionine administration for the diagnosis of suspected recurrent brain tumors.11C-methionine PET/CT findings in benign brain disease.Clinical Utility of Positron Emission Tomography in Patients with Malignant Glioma.Epilepsy surgery of dysembryoplastic neuroepithelial tumors using advanced multitechnologies with combined neuroimaging and electrophysiological examinations [ (11) C]-methionine positron emission tomography in the postoperative imaging and followup of patients with primary and recurrent gliomas.Technetium Tc99m tetrofosmin single-photon emission CT for the assessment of glioma proliferation.Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.¹¹C-methionine uptake and intraoperative 5-aminolevulinic acid-induced fluorescence as separate index markers of cell density in glioma: a stereotactic image-histological analysis.Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis.Calcifying pseudoneoplasm of the neuraxis in direct continuity with a low-grade glioma: A case report and review of the literature.Evaluation of brain tumors using dynamic 11C-methionine-PET.

P2860

Q24605136-846D8027-18FE-4C8E-A6A6-3D6C1D8BC70B Q26773119-53F9F332-33D2-441F-88D3-AF1F37FF61BF Q27008911-F2F9D651-2112-4597-8C5B-0E530F8E003A Q30586066-64A7E0B0-AAB4-433E-BFA6-4F32FC585D46 Q30672749-11A63135-19BD-4746-8EFE-E66944E26320 Q30714285-7AEE68DF-3FBE-4C8E-934F-D40BC77FF4B4 Q31102805-7BD79368-0A7D-4A25-8857-4B6D1BB39CB3 Q33516753-09BA102C-4639-44C4-8436-29755D8C7A20 Q33746805-1567C218-DDAB-4719-B554-5F7E89D47A8C Q33961188-8B38CBF3-DD03-4157-A80C-2B26707CB5E0 Q34336127-16FE9A34-6162-4587-82B9-8DF6A11F25A1 Q35103565-8B2D67A1-0D05-439C-9A2B-9F7CD064091D Q35650841-632A4B6E-2064-4FBF-8E27-18DE1529BBC6 Q35688086-C81BA97D-53BD-4CD1-9780-4B9C6E5EBE2C Q35785243-DD8600A0-AB8C-496D-9A72-1F863F201D4A Q35835743-BC2103BB-A742-43EF-A8F8-491BFF20697A Q35914520-23DD2E66-C8EB-4C0F-903E-EBD2BEC36EF1 Q35943921-F60C2AD1-4934-4E8A-BB49-860414FDDA94 Q36037169-F199606F-EAD5-42B0-8C13-41CE3EC3E733 Q36210293-38F3B635-480B-4DE7-A188-A14C1ED61665 Q36404866-8CD07BEE-9379-4C28-8C50-B1F06B3E14BC Q36949701-4B1B689D-AF3E-49FC-A4D8-E7B2FD721E1B Q37212449-8CEAA26C-E2E8-49C6-ABFE-E03D25190887 Q37235829-4B8902E1-3E9E-4A3E-A162-0F321DE83F97 Q37720011-F4E286DB-6A52-4B95-B823-31641664D97A Q38008241-B793F644-FC20-4DAB-997B-DF802DE58732 Q38670632-425B4A8F-D9D3-405D-AAAE-AB68074CB8D5 Q38691946-7CBD078A-EB2E-41D1-B267-BA8057070DC4 Q38947519-17A61E48-7952-427D-BF4A-C838573975B0 Q39155152-A6D79421-9477-4E16-AFAA-EFA27E6D5910 Q39249830-06BB2526-2D2F-433E-B84B-69378FA23C9F Q39274022-FF8D700D-ED70-4C27-9A0C-0CCB79A976B4 Q41455495-5C11CA06-2427-47BB-964E-192E46EE9087 Q41871381-922B1D74-A8C0-4A60-8C99-2BD60674C3C0 Q46247409-8E8C1B9D-BEC5-4931-992F-70C708144CEC Q46454434-8681A5AA-52D4-423D-90E2-D4D787DAE792 Q46802356-8DA99CF0-5FBE-4251-A654-5EB525CB7D55 Q47367363-4E2C8CE4-C4D3-440C-8B51-F3687A9E6218 Q48306619-0E3B95D4-98FB-4341-BF49-A3EAAFDBC383 Q48552254-E132682D-DE83-457E-B233-7B34B60FB9CA

P2860

Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.

http://www.wikidata.org/entity/Q46664735

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Metabolic assessment of glioma ...... positron-emission tomography.

@en

Metabolic assessment of glioma ...... positron-emission tomography.

@nl

type

label

Metabolic assessment of glioma ...... positron-emission tomography.

@en

Metabolic assessment of glioma ...... positron-emission tomography.

@nl

prefLabel

Metabolic assessment of glioma ...... positron-emission tomography.

@en

Metabolic assessment of glioma ...... positron-emission tomography.

@nl

P1433

Q46664735-0F48424C-9A50-4323-93AC-54ABB564D8B8

P1476

Q46664735-F1475AC3-0A5A-4CD0-A378-4910A382FC20

P2093

Q46664735-172B01B3-2E85-4710-B9B0-3149FA63D231

Q46664735-1FDEE7B2-513A-4C4C-A69D-922050BB1111

Q46664735-2B51A57E-F70D-4106-A462-AB3CD7645AB6

Q46664735-453243B0-8AE3-4F6B-881F-CDAA33BF1052

Q46664735-46F7EA2B-4522-408E-85E4-51FAF3321FB0

Q46664735-5A0D8AA8-15C9-476F-BB47-77589656C12B

Q46664735-6F94432B-669C-4AC9-A990-E42F975A5262

Q46664735-77D20A49-D837-430C-BAD2-2F7D5DCB3A25

Q46664735-79A22683-E4C9-47B2-809D-606F09C56207

Q46664735-EE715DA3-58EB-4509-9C96-14A6FC903C91

P2860

Q46664735-2E863EDE-0AD2-42C4-B185-DFA46FA3E90F

Q46664735-2F4EFD32-E4EE-49B9-9306-FDA9BC527033

Q46664735-453988F3-2BDF-4489-A050-B74D855BB0EA

Q46664735-4C91CBF1-D000-4D60-9860-AD93B17C37B9

Q46664735-4D4CC813-B730-4943-A19D-05692BDB7013

Q46664735-540149F8-580F-422B-9E1C-6A281CA599D5

Q46664735-559416AE-DDB8-4B35-861D-4FBB7EECAA2B

Q46664735-673F5082-96D1-4F93-A08D-392475EEB9C5

Q46664735-684D0728-2021-466B-844B-325939E40532

Q46664735-849307BD-16D4-4252-AF4B-409B835D8900

P304

Q46664735-1D1A8C44-D61E-4B5F-892D-C51835A5CAF4

P31

Q46664735-EE812A8C-3B5F-43C0-ADD0-06F65A92FBAD

P356

Q46664735-1D387EC7-5279-4EFC-A9FF-A7A8663CD43E

P433

Q46664735-A12F2060-137A-4F18-B2BF-FEF5F227B296

P478

Q46664735-3805A0A5-C8CC-4C0C-897B-E6F3DFBF9FDA

P577

Q46664735-D49578A9-E34D-41C5-A744-16A413CF1DF6

P698

Q46664735-6FFBE837-F659-410B-9055-68BD548E7637

P356

P1433

American Journal of Neuroradiology

P1476

Metabolic assessment of glioma ...... positron-emission tomography.

@en

P2093

A Okumura

http://www.w3.org/2001/XMLSchema#string

H Yano

http://www.w3.org/2001/XMLSchema#string

J Shinoda

http://www.w3.org/2001/XMLSchema#string

K Miwa

http://www.w3.org/2001/XMLSchema#string

N Nakayama

http://www.w3.org/2001/XMLSchema#string

S Yoshimura

http://www.w3.org/2001/XMLSchema#string

T Iwama

http://www.w3.org/2001/XMLSchema#string

T Kato

http://www.w3.org/2001/XMLSchema#string

T Maruyama

http://www.w3.org/2001/XMLSchema#string

Y Muragaki

http://www.w3.org/2001/XMLSchema#string

P2860

The prognostic role of vessel productive changes and vessel density in oligodendroglioma.

Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.

Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study.

Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.

A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglucose in human astrocytoma.

Angiogenesis in malignant gliomas.

FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.

Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma.

11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET.

Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

P304

1176-1182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3174/AJNR.A1008

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18388218

http://www.w3.org/2001/XMLSchema#string